Premenstrual Dysphoric Disorder (PMDD) – Drug Treatments Source: CureJoy The pathogenesis of Premenstrual Dysphoric Disorder (PMDD) is unclear, but evidence suggests a link between PMDD and a physiological sensitivity to normal fluctuations of the menstrual cycle hormones oestrogen and progesterone…. Read More ›
Genomics: The Promised Land of Breakthroughs for Pharma Source: Genetic Literary Project Pharma’s breakthroughs have been scarce of late. A good portion of clinical trials on new medicines fail and current drugs don’t work equally well in all patients living… Read More ›
Medicine 2.0: The Future of Digital Medicine “Technology is reshaping our reality.” – John Nosta, Founder, NOSTALAB Photo Source: Tony Kane Consulting Imagine this: a smart contact lens in your eye; a digital pill fitted with a sensor to… Read More ›
Pharma’s Role in Cancer Survivorship Although the cancer-cure revolution has yet to dawn upon us, research has made significant inroads into beating, or at least fighting, the disease. Advances in medical research and technology, improved diagnosis and therapies, and better patient… Read More ›
Powering Drug Commercialisation through Small Data Credit: socialmediaexplorer.com Over the past decade, several technological advances have taken place in the healthcare sector globally. One of the largest advances is that pharmaceutical companies, insurers and providers have been digitising their research… Read More ›
The Science and Application of Behaviour Change in Pharma Credit: Neil Adler At the core of any change within a company is the need for concomitant change in individual and collective behaviour. Internationally, pharma is facing growing pressure… Read More ›
Mergers and Acquisition in Big Pharma When your average consumer is asked their opinion about Big Pharma – large pharmaceutical companies – they may feel ambivalence. They may have a loved one on a regimen of a life-changing, even… Read More ›
3 Impressive Innovations in Pharmaceutical Service Delivery In recent years, pharmaceutical companies have come under a lot of criticism for not giving enough consideration to the end users of their products – the patients – and instead prioritising the… Read More ›
Why Businesses are Failing at ‘Social Listening’ Listening is the only way we get first-hand accounts of the experiences of other people. And the growth of social media has encouraged conversations to be more transparent, with the size… Read More ›
Pharma’s Priorities in 2016: Affordability and Public Health Many pharmaceutical and biotech companies have been busy striking merger and acquisition (M&A) deals in 2015. According to Ernst & Young Global Limited, the volume of deals grew by 21.5% from… Read More ›
What are Pharma doing for Mental Health? Governments are increasingly worried about the state of people’s mental health – and for good reason. In the United States, the cost of lost wages, health care, and disability is approximately $317… Read More ›
Pharma Flops and Feats Pharmaceuticals have helped us to live longer and enjoy greater quality of life, but there have also been instances in which things didn’t work out quite as planned. I investigated ten recent examples that illustrate the… Read More ›
